About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Voluntary Withdrawal from OTCQX
December 3, 2018
Click here to read more
Post navigation
Previous Post
Receipt of R&D Tax Incentive
Next Post
Phosphagenics and Mylan Agree Settlement
Related Posts
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
May 16, 2024
Quarterly Shareholder Update
July 1, 2015
Ethics Approval for amendments to Phase III Clinical Trial
March 7, 2024
March 7, 2024